Durability of immune responses to the BNT162b2 mRNA vaccine

Antibody responses to the Pfizer-BioNTech mRNA vaccine waned substantially 6 months after the second vaccination. Substantial waning of antibody responses to the Pfizer-BioNTech mRNA vaccine 6 months after the second vaccination.

Saved in:
Bibliographic Details
Published inMed (New York, N.Y. : Online) Vol. 3; no. 1; pp. 25 - 27
Main Authors Suthar, Mehul S., Arunachalam, Prabhu S., Hu, Mengyun, Reis, Noah, Trisal, Meera, Raeber, Olivia, Chinthrajah, Sharon, Davis-Gardner, Meredith E., Manning, Kelly, Mudvari, Prakriti, Boritz, Eli, Godbole, Sucheta, Henry, Amy R., Douek, Daniel C., Halfmann, Peter, Kawaoka, Yoshihiro, Boyd, Scott D., Davis, Mark M., Zarnitsyna, Veronika I., Nadeau, Kari, Pulendran, Bali
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 14.01.2022
Subjects
Antibody Formation
BNT162 Vaccine
COVID-19 - prevention & control
COVID-19 Vaccines
Humans
mRNA Vaccines
Vaccines, Synthetic
Online AccessGet full text

Cover

More Information
Summary:Antibody responses to the Pfizer-BioNTech mRNA vaccine waned substantially 6 months after the second vaccination. Substantial waning of antibody responses to the Pfizer-BioNTech mRNA vaccine 6 months after the second vaccination.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
These authors contributed equally.
ISSN:2666-6340
2666-6359
2666-6340
DOI:10.1016/j.medj.2021.12.005